Results 141 to 150 of about 383,296 (267)
Demographics and disparities in cardiomyopathy and ischemic heart disease mortality among U.S. adults >65 years: CDC WONDER 1999-2024 analysis. [PDF]
Fatima Y +8 more
europepmc +1 more source
ALDH2 deficiency promotes 4‐HNE accumulation, resulting in covalent modification of HSP60, disruption of its oligomeric assembly, and VDAC1‐dependent release of HSP60 from mitochondria to the cytosol. Pharmacological activation of ALDH2 preserves HSP60 proteostasis and mitochondrial integrity, whereas the clinical association between the ALDH2 rs671 ...
You‐Cheng Lin +7 more
wiley +1 more source
Proteome-wide genetic analyses identify ASGR1 as a potential biomarker linking smoking with ischemic heart disease. [PDF]
Tinworth AC +9 more
europepmc +1 more source
A bioengineered mitochondrial respiration‐mimetic nanoplatform (TC@OMG) renews tumor mitochondrial metabolism to enhance cuproptosis. TC@OMG integrates a copper‐based metal‐organic framework co‐loaded with glucose oxidase and a lactate dehydrogenase inhibitor, and is cloaked with a hybrid membrane derived from tumor cells and plant thylakoids, enabling
Liyang Zhou +7 more
wiley +1 more source
Laterality of Breast Radiotherapy and Ischemic Heart Disease by Cardiovascular Risk Burden.
Chung SY, Noh OK.
europepmc +1 more source
Pathological Q Waves in a Young Patient Without Ischemic Heart Disease. [PDF]
Figueroa-Galván FS +6 more
europepmc +1 more source
An injectable, microenvironment‐responsive hydrogel (HAPOCS@CDNVs) is developed for sustained delivery of Cistanche deserticola‐derived nanovesicles (CDNVs). By scavenging ROS, restoring mitochondrial function, and attenuating SASP, this platform effectively suppresses nucleus pulposus cell senescence and facilitates extracellular matrix reconstruction,
Ning Xu +11 more
wiley +1 more source
Myocardiocyte senescence in ischemic heart disease and breathome changes. [PDF]
Marzoog BA, Kopylov P.
europepmc +1 more source
A unifying device–cardiovascular interface framework is presented to classify implantable cardiovascular technologies as intracardiovascular blood‐contacting systems or extracardiovascular tissue‐only and blood‐handling architectures. Cross‐class comparison across shared semiquantitative criteria, including blood‐contact burden, biomimicry ...
Bergo Nicolò +7 more
wiley +1 more source
Regional Heterogeneity in Ischemic Heart Disease and Ischemic Stroke Burden in Europe, 1990-2023: GBD 2023 and Complementary Mendelian Randomization Evidence. [PDF]
Hu H +5 more
europepmc +1 more source

